Description

2(1H)-Quinoxalinone, 7-Bromo-8-Fluoro-3,4-Dihydro-3-Methyl- is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound is critical for medicinal chemistry research and development, particularly in the creation of novel drug candidates targeting various therapeutic areas. It is essential for pharmaceutical manufacturers, contract research organizations (CROs), and academic research institutions engaged in the development of new chemical entities.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop new pharmacophores.
• API Development: Serves as a crucial precursor in the multi-step synthesis of complex active pharmaceutical ingredients (APIs).
• Chemical Biology Probes: Utilized in the development of chemical probes for studying biological pathways and target validation.
• Agrochemical Research: Potential application as an intermediate in the research and development of new crop protection agents.
• Material Science: Investigated for use in the synthesis of specialty polymers and organic electronic materials due to its heterocyclic structure.

Basic Information

Product Name	2(1H)-Quinoxalinone, 7-Bromo-8-Fluoro-3,4-Dihydro-3-Methyl-
CAS No.	2756334-24-2
Molecular Formula	C10H8BrFN2O
Molecular Weight	271.09 g/mol
Synonyms	7-Bromo-8-fluoro-3-methyl-3,4-dihydro-1H-quinoxalin-2-one; 7-Bromo-8-fluoro-3-methyl-1,2,3,4-tetrahydroquinoxalin-2-one; 3,4-Dihydro-7-bromo-8-fluoro-3-methyl-2(1H)-quinoxalinone; 2756334-24-2; 7-Br-8-F-3-Me-DHQO
EINECS	Contact for details

Quality Control

Our 2(1H)-Quinoxalinone, 7-Bromo-8-Fluoro-3,4-Dihydro-3-Methyl- is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications and test results. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your critical research and development projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.